How Do Patients Contribute to Signal Detection?A Retrospective Analysis of Spontaneous Reporting of Adverse Drug Reactions in the UK’s Yellow Card Scheme

被引：0
|
作者：
Lorna Hazell
Victoria Cornelius
Philip Hannaford
Saad Shakir
Anthony J. Avery
机构：
[1] Drug Safety Research Unit,Institute of Applied Health Sciences
[2] Bursledon Hall,Division of Primary Care, The Medical School
[3] University of Aberdeen,School of Pharmacy and Biomedical Sciences
[4] University of Nottingham,undefined
[5] University of Portsmouth,undefined
来源：
Drug Safety | 2013年 / 36卷
关键词：
Atomoxetine; Patient Report; Suspect Drug; System Organ Class; Proportional Reporting Ratio;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：199 / 206
页数：7
相关论文
共 36 条
  • [1] How Do Patients Contribute to Signal Detection? A Retrospective Analysis of Spontaneous Reporting of Adverse Drug Reactions in the UK's Yellow Card Scheme
    Hazell, Lorna
    Cornelius, Victoria
    Hannaford, Philip
    Shakir, Saad
    Avery, Anthony J.
    DRUG SAFETY, 2013, 36 (03) : 199 - 206
  • [2] The Yellow Card Scheme for reporting adverse drug reactions (ADRs) by patients in the UK will complement, not replace, the Yellow Card reports
    Reactions Weekly, 2006, 1109 (1) : 3 - 3
  • [3] Public awareness in Wales of the UK Yellow Card scheme for reporting suspected adverse drug reactions
    Bracchi, Robert C.
    Tseliou, Foteini
    Copeland, Lauren
    Routledge, Philip A.
    Thomas, Alison
    Woods, Fiona
    Adams, Alana
    Walker, Jenna
    Jadeja, Mitul
    Atkinson, Mark D.
    Ashfield-Watt, Pauline
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (08) : 3344 - 3348
  • [4] Assessing the usability of methods of public reporting of adverse drug reactions to the UK Yellow Card Scheme
    Anderson, Claire
    Gifford, Alison
    Avery, Anthony
    Fortnum, Heather
    Murphy, Elizabeth
    Krska, Janet
    Bond, Christine
    HEALTH EXPECTATIONS, 2012, 15 (04) : 433 - 440
  • [5] How Patient Reporters Identify Adverse Drug Reactions A Qualitative Study of Reporting via the UK Yellow Card Scheme
    Krska, Janet
    Anderson, Claire
    Murphy, Elizabeth
    Avery, Anthony J.
    DRUG SAFETY, 2011, 34 (05) : 429 - 436
  • [6] The yellow card scheme: Evaluation of patient reporting of suspected adverse drug reactions
    Ekins-Daukes, S.
    Irvine, D.
    Wise, L.
    Fiddes, S.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S105 - S105
  • [7] The Yellow Card Scheme: Patient Reporting of Adverse Drug Reactions and Signals they have Generated
    Foy, M.
    Gandhi, S.
    Suri, S.
    Cumber, S.
    Jadeja, M. M.
    DRUG SAFETY, 2011, 34 (10) : 903 - 903
  • [8] Identifying and managing adverse drug reactions: Qualitative analysis of patient reports to the UK yellow card scheme
    O'Donovan, Bernadine
    Rodgers, Ruth M.
    Cox, Anthony R.
    Krska, Janet
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (07) : 3434 - 3446
  • [9] How Patient Reporters Identify Adverse Drug ReactionsA Qualitative Study of Reporting via the UK Yellow Card Scheme
    Janet Krska
    Claire Anderson
    Elizabeth Murphy
    Anthony J. Avery
    Drug Safety, 2011, 34 : 429 - 436
  • [10] Adverse Drug Reaction Reporting in the UK A Retrospective Observational Comparison of Yellow Card Reports Submitted by Patients and Healthcare Professionals
    McLernon, David J.
    Bond, Christine M.
    Hannaford, Philip C.
    Watson, Margaret C.
    Lee, Amanda J.
    Hazell, Lorna
    Avery, Anthony
    DRUG SAFETY, 2010, 33 (09) : 775 - 788
1234